Timucin Avsar

Brain Tumors, hematopoietic stem cells

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Atabay KD, Yildiz MT, Avsar T, et al. (2015) Knockdown of Pin1 leads to reduced angiogenic potential and tumorigenicity in glioblastoma cells. Oncology Letters. 10: 2385-2389
Karal-Yilmaz O, Ozkan A, Akgun E, et al. (2013) Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis. Journal of Materials Science. Materials in Medicine. 24: 147-53
Yener U, Avsar T, Akgün E, et al. (2012) Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay. Journal of Neurosurgery. 117: 697-704
Avsar T, Akgun E, Yılmaz OK, et al. (2011) Abstract B48: Inhibition of recurrence of craniopharyngiomas with imatinib mesylate-loaded poly(lactide-co-glycolide) (PLGA) microspheres Cancer Prevention Research. 4
Avsar T, Atabay KD, Mehmet YT, et al. (2011) Abstract A31: Effects of Pin1 inhibition on tumorigenicity of glioblastoma multiforme Cancer Prevention Research. 4
Avsar T, Yener U, Akgun E. (2011) Abstract A30: Investigation of imatinib mesylate effect on vestibular schwannoma tumor by using in vivo corneal angiogenesis model Cancer Prevention Research. 4